You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
This multidisciplinary book provides up-to-date coverage of carrier and spin dynamics and energy transfer and structural interaction among nanostructures. Coverage also includes current device applications such as quantum dot lasers and detectors, as well as future applications to quantum information processing. The book will serve as a reference for anyone working with or planning to work with quantum dots.
Glaucoma Clinical Care: The Essentials is a pragmatic, slimmer companion volume to the more academically focused text “The Glaucoma Book” by the same editors. This new book is a thoroughly updated manual for the day-to-day diagnosis and management of glaucoma patients by comprehensive ophthalmologists and optometric physicians. Its 33 chapters are authored by world renowned experts in clinical care and basic research, providing evidenced-based research, office examination skills, clinical pearls, and up-to-date reviews of the scientific literature on glaucoma, as wel l as extensive graphics and tables to accompany the text. Glaucoma Clinical Care: The Essentials is the one book to have and consult when confronted with a problematic glaucoma patient sitting in your exam chair as it is a thorough presentation of glaucoma medications, laser, and incisional glaucoma surgeries, complete with commentaries on advantages and disadvantages of the different therapies.
This book provides state-of-the-art reviews of key issues and recent developments relating to chronic myeloid leukemia (CML), acquainting the reader with advances in research, treatment, and promotion of public health. Among the management topics addressed are the choices, advantages, and pitfalls of first-, second-, and third-line treatments; the European LeukemiaNet recommendations; management of adverse effects of tyrosine kinase inhibitors (TKI); management of CML blast crisis; management of pregnancy in the context of CML; the role of hematopoietic cell transplantation; the current experience with TKI discontinuation; and the value of interferon α in improving the outcome of TKI treatment. Various aspects of relevance to treatment outcome are discussed, including prognostic scores, molecular monitoring (principles and interlaboratory standardization), and response-related predictors of survival. Furthermore, updates are provided on the increasing prevalence of CML and its implications and on the changing cost of care for CML, taking into account the impact of availability of generic imatinib.
The understanding of functional groups is key for the understanding of all organic chemistry. In the tradition of the Patai Series each volume treats all aspects of functional groups. Each volume contains chapters on the theoretical and physicochemical foundations; on analytical aspects; on reaction mechanisms; on applications in synthesis. Depending on the functional group there are additional chapters on industrial use, on medical use, and on human and environmental toxicity issues. The last volume in the series on the topic (Peroxides Vol. 2) was published in 2006. In the eight years since then a lot of developments have taken place, especially in the areas of synthesis, analysis and a better theoretical understanding of the reaction mechanism, all of which are covered here. As with all new volumes, the chapters are first published online in Patai's Chemistry of Functional Groups. Once a volume is completed online, it is then published in print format. The printed book offers the traditional quality of the Patai Book Series, complete with an extensive index.
This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of “de-risking” that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.
Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.